Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.

Bolland, Mark J

Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. [electronic resource] - The Journal of clinical endocrinology and metabolism Apr 2007 - 1283-8 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0021-972X

10.1210/jc.2006-2216 doi


Adult
Antiretroviral Therapy, Highly Active
Body Mass Index
Body Size
Bone Density--drug effects
Bone Density Conservation Agents--administration & dosage
Diphosphonates--administration & dosage
Drug Administration Schedule
HIV Infections--drug therapy
Humans
Imidazoles--administration & dosage
Male
Middle Aged
Placebos
Zoledronic Acid